Answers are grounded in this paper and cite their sources.
Our results emphasize the general cancer proclivity of patients with NF1. These findings should translate to clinical practices to determine clinical interventions and focused follow-up of patients with NF1.
No takes yet. Share an insight, caveat, or question.
Uusitalo et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: